Baytril 25 mg/ml Solution for Injection

Χώρα: Ηνωμένο Βασίλειο

Γλώσσα: Αγγλικά

Πηγή: VMD (Veterinary Medicines Directorate)

Δραστική ουσία:

Enrofloxacin

Διαθέσιμο από:

Elanco Europe Ltd

Φαρμακολογική κατηγορία (ATC):

QJ01MA90

INN (Διεθνής Όνομα):

Enrofloxacin

Φαρμακοτεχνική μορφή:

Solution for injection

Τρόπος διάθεσης:

POM-V - Prescription Only Medicine – Veterinarian

Θεραπευτική ομάδα:

Cats, Dogs, Ornamental Birds, Pigs, Rabbits, Reptiles, Rodents

Θεραπευτική περιοχή:

Antimicrobial

Καθεστώς αδειοδότησης:

Authorized

Ημερομηνία της άδειας:

1992-04-22

Αρχείο Π.Χ.Π.

Revised: September 2023
AN: 03529/2022
Page 1 of 8
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Baytril 25 mg/ml solution for injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One ml solution contains:
ACTIVE SUBSTANCE:
Enrofloxacin 25 mg
EXCIPIENT:
n-Butyl alcohol30 mg.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear light-yellow solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs, cats, pigs (piglets), rabbits, rodents, reptiles and ornamental
birds.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
DOGS
Treatment of infections of the alimentary, respiratory and urogenital
tracts
(including
prostatitis,
adjunctive
antibiotic
therapy
for
pyometra),
skin
and
wound infections, otitis (externa/media) caused by enrofloxacin
susceptible
strains of: _ Staphylococcus _ spp_., Escherichia coli, Pasteurella _
spp_., Klebsiella _
spp_., Bordetella _spp_., Pseudomonas _spp_. _and _Proteus _spp_._
CATS
Treatment of infections of the alimentary, respiratory and urogenital
tracts (as
adjunctive antibiotic therapy for pyometra), skin and wound
infections, caused
by enrofloxacin susceptible strains of: _ Staphylococcus _ spp_.,
Escherichia coli, _
_Pasteurella _ spp_., Klebsiella _ spp_., Bordetella _ spp_.,
Pseudomonas _ spp_. _ and
_Proteus _spp.
PIGS (PIGLETS)
Treatment
of
infections
of
the
respiratory
tract
caused
by
enrofloxacin
susceptible strains of: _Pasteurella multocida, Mycoplasma _spp_.,
Actinobacillus _
_pleuropneumoniae_.
Revised: September 2023
AN: 03529/2022
Page 2 of 8
Treatment
of
infections
of
the
alimentary
tract
caused
by
enrofloxacin
susceptible strains of _Escherichia coli._
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia coli_.
RABBITS
Treatment of infections of the alimentary and respiratory tracts
caused by
enrofloxacin susceptible strains of: _Escherichia coli_, _Pasteurella
multocida _and
_Staphylococcus _spp.
Treatment of skin and wound infections caused by enro